GBS variant | Level of diagnostic certainty | |||
Level 1 | Level 2 | Level 3 | Level 4 | |
Sensorimotor and motor variants | Bilateral and flaccid weakness of the limbs AND Decreased or absent deep tendon reflexes in weak limbs AND Monophasic illness with weakness nadir 12 hours to 28 days from the onset and subsequent clinical plateau AND Absence of an alternative diagnosis | Suspected GBS with no other diagnosis apparent, which does not meet level 3 criteria | ||
CSF white cell count <50 cells/µL OR If CSF unavailable, electrophysiological studies consistent with GBS | - | |||
CSF white cell count <50 cells/µL with raised CSF protein AND Electrophysiological studies consistent with GBS | - |
Level 1 | Level 2 | Level 3 | Level 4 | |
Miller Fisher Syndrome | Bilateral ophthalmoparesis AND Bilateral decreased or absent tendon reflexes AND Ataxia AND Monophasic illness with weakness nadir 12 hours to 28 days from the onset and subsequent clinical plateau AND Absence of limb weakness AND Absence of alterations in consciousness or corticospinal tract signs AND Absence of an alternative diagnosis | Suspected Miller Fisher syndrome with no other diagnosis apparent, which does not meet level 3 criteria | ||
CSF white cell count <50 cells/µL OR Nerve conduction studies normal OR show involvement of sensory nerves only | - | |||
CSF white cell count <50 cells/µL with raised CSF protein AND Nerve conduction studies normal OR show involvement of sensory nerves only | - |
Level 1 | Level 2 | Level 3 | Level 4 | |
Facial diplegia with paraesthesias | Bilateral lower motor neuron facial weakness AND Bilateral paraesthesia of the lower and/or upper limbs AND Absence of limb weakness AND Monophasic illness with weakness nadir 12 hours to 28 days from the onset and subsequent clinical plateau AND Absence of an alternative diagnosis | Suspected facial diplegia with paraesthesias variant with no other diagnosis apparent, which does not meet level 3 criteria | ||
CSF white cell count <50 cells/µL OR If CSF unavailable, electrophysiological studies consistent with GBS | - | |||
CSF white cell count <50 cells/µL with raised CSF protein AND Electrophysiological studies consistent with GBS | - |
CSF, cerebrospinal fluid.